Sep 2026
Wuwei Huanglian Wan inhibits Helicobacter pylori and alleviates associated gastritis: host metabolic remodeling and altered IL-6/STAT3 signaling.
The therapeutic effects of WWHLW were evaluated through in vitro antibacterial assays and an H. pylori-infected mouse model, and integrated metabolomics and network pharmacology analyses revealed alterations in lipid and amino acid-related metabolic pathways following WWHLW treatment.
Wen-Xi Yang, Geng-Geng Yu, Ya-Nan Zhang et al.
· Journal of Ethnopharmacology · 0 citations